In the past, people with postpartum depression (PPD) relied on traditional antidepressants. This included SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin and norepinephrine reuptake inhibitors).
In this video, learn about new FDA-approved medications specifically for PPD, according to Naomi Torres-Mackie, PhD, Clinical Psychologist at Lenox Hill Hospital, Northwell Health.
Naomi Torres-Mackie, PhD, is a Clinical Psychologist at Lenox Hill Hospital, Northwell Health.
References
American College of Obstetricians and Gynecologists. (2021). Postpartum depression.
Azhar, Y., et al. (2022). Brexanolone. StatPearls.
Frieder, A., et al. (2019). Pharmacotherapy of postpartum depression: Current approaches and novel drug development. CNS Drugs.
Mughal, S., et al. (2022). Postpartum depression. StatPearls.
U.S. Food and Drug Administration. (2019). FDA approves first treatment for postpartum depression.
U.S. Food and Drug Administration. (2023). FDA approves first oral treatment for postpartum depression.
U.S. Office on Women’s Health. (2023). Postpartum depression.
Viguera, A. (2023). Mild to moderate postpartum unipolar major depression: Treatment. UpToDate.
Viguera, A. (2023). Severe postpartum unipolar major depression: Choosing treatment. UpToDate.
Why trust our experts?
